Skip to main content
S 3635 116th Congress Senate Health Asia Business expenses China Drug safety, medical device, and laboratory regulation Government information and archives Health care costs and insurance Health programs administration and funding Health technology, devices, supplies Income tax deductions Manufacturing Military medicine Military procurement, research, weapons development Prescription drugs Public contracts and procurement Trade restrictions Veterans' medical care

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Introduced: May 6, 2020 Introduced by: Cotton, Tom Republican · Arkansas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 6, 2020
Read twice and referred to the Committee on Finance.
May 6, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.

What's happening now May 6, 2020

Read twice and referred to the Committee on Finance.

 Related & companion bills 2
  • S 3537 Related bill Protecting Our Pharmaceutical Supply Chain from China Act of 2020
  • HR 6482 Related bill Protecting Our Pharmaceutical Supply Chain from China Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Republican 4
R
Blackburn, Marsha
Tennessee · May 6, 2020
 R
Cruz, Ted
Texas · May 6, 2020
 R
Daines, Steve
Montana · May 6, 2020
 R
Scott, Rick
Florida · May 6, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3635: Protecting Our Pharmaceutical Supply Chain from China Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3635/
MLA
"S. 3635: Protecting Our Pharmaceutical Supply Chain from China Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3635/.
Bluebook (legal)
S. 3635, 116th Cong. (2026), https://openamerica.io/bill/116-S-3635/.
Markdown link
[S. 3635: Protecting Our Pharmaceutical Supply Chain from China Act of 2020](https://openamerica.io/bill/116-S-3635/)
Report a problem